^
Association details:
| Biomarker: | EGFR G724S + EGFR R776H |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug: | Gilotrif (afatinib) (EGFR inhibitor, HER2 inhibitor, HER4 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
P76.06 - A Novel EGFR G724S and R776H Rare Co-Mutation Response to Afatinib in a Patient With Lung Adenocarcinoma
Published date:
01/12/2021
Excerpt:
This is the first report of co-mutation of EGFR R776H/G724S in a patient with lung adenocarcinoma. Afatinib may be a beneficial therapeutic option for a subset of NSCLC with rare EGFR co-mutation.
